© 2020 MJH Life Sciences and Modern Retina. All rights reserved.
© 2020 MJH Life Sciences™ and Modern Retina. All rights reserved.
PEDIATRIC ASSOCIATES AT NORTHWOODS
2007 BAY ST
Cheryl Guttman is a medical writer based in Deerfield, Ill.
November 01, 2020
Phase 1b data show improved vision and reduced macular edema in patients, with only 3 loading doses and minimal re-treatments.
Results support further research investigating transforming growth factor-β-Induced Gene Human Clone 30 (BIGH3).
Manufacturers are stepping up to design products that will help maximize the safety and efficiency of intravitreal injection.
The benefit is robust across a variety of demographics and baseline disease characteristics, according to data.